Glenmark Pharmaceuticals has launched Prasugrel, a revolutionary new anti-platelet drug for the management of Acute Coronary Syndrome with PCI (Percutaneous Coronary Intervention) for the first time in India. PCI is better known as the angioplasty procedure which normally includes the placement of a stent to keep the artery open.
Source :www.biginfotech.in
No comments:
Post a Comment